Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial.

[1]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.

[2]  P. Ponikowski,et al.  Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial. , 2016, JACC. Heart failure.

[3]  A. Peters,et al.  Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium , 2016, European heart journal.

[4]  P. Ponikowski,et al.  Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX‐AHF study , 2015, European journal of heart failure.

[5]  P. Ridker,et al.  High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention , 2015, Circulation.

[6]  S. Hazen,et al.  Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. , 2015, The American journal of medicine.

[7]  R. Califf,et al.  Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. , 2015, JACC. Heart failure.

[8]  P. Ponikowski,et al.  Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. , 2013, Journal of the American College of Cardiology.

[9]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[10]  W. W. Tang,et al.  Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review , 2012, Heart.

[11]  L. Tavazzi,et al.  Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure: Data From 2 Large Randomized Clinical Trials , 2012, Circulation.

[12]  V. Hasselblad,et al.  Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study , 2011, European journal of heart failure.

[13]  Carlo Lombardi,et al.  Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure: Analysis From the PROTECT Pilot Study , 2011, Circulation. Heart failure.

[14]  L. Deckelbaum,et al.  Effect of nesiritide in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[15]  S. Manzano-Fernández,et al.  Soluble ST2, high‐sensitivity troponin T‐ and N‐terminal pro‐B‐type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure , 2011, European journal of heart failure.

[16]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[17]  W. Peacock,et al.  Serial changes in high‐sensitive troponin I predict outcome in patients with decompensated heart failure , 2011, European journal of heart failure.

[18]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[19]  Christopher M O'Connor,et al.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.

[20]  V. Hasselblad,et al.  Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). , 2009, American heart journal.

[21]  G. Fonarow,et al.  Cardiac troponin and outcome in acute heart failure. , 2008, The New England journal of medicine.

[22]  R. Schrier.  Blood urea nitrogen and serum creatinine: not married in heart failure. , 2008, Circulation. Heart failure.

[23]  J. Todd,et al.  Ultrasensitive flow-based immunoassays using single-molecule counting. , 2007, Clinical chemistry.

[24]  J. Cohn,et al.  Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure , 2007, Circulation.

[25]  C. Specchia,et al.  The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT‐proBNP and cardiac troponin‐T , 2007, European journal of heart failure.

[26]  Peter C Austin,et al.  Relation between cardiac troponin I and mortality in acute decompensated heart failure. , 2007, American heart journal.

[27]  E. Perna,et al.  Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  A. Khera,et al.  Prevalence and Determinants of Troponin T Elevation in the General Population , 2006, Circulation.

[29]  K. Ohno,et al.  Plasma Concentrations of Brain Natriuretic Peptide in Patients with Acute Ischemic Stroke , 2005, Cerebrovascular Diseases.

[30]  J. Canty,et al.  Preload Induces Troponin I Degradation Independently of Myocardial Ischemia , 2001, Circulation.

[31]  M. Kinoshita,et al.  Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. , 1998, American heart journal.

[32]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .